|
1 Company |
|
3 Products |
|
3 Products |
|
1 Mechanism of Action |
|
0 Trials |
|
22 News |
|
- | Trial completion, Trial completion date, Trial primary completion date: Use of Copeptin in Diabetes Insipidus (clinicaltrials.gov) - Apr 17, 2018
P=N/A, N=156, Completed, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed | Trial completion date: Dec 2018 --> Dec 2017 | Trial primary completion date: Dec 2018 --> Jun 2017
- | Trial completion, Enrollment change: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome (clinicaltrials.gov) - Jul 11, 2017
P=N/A, N=60, Completed, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed | Trial completion date: Dec 2018 --> Dec 2017 | Trial primary completion date: Dec 2018 --> Jun 2017 Recruiting --> Completed | N=40 --> 60
- | Trial primary completion date: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome (clinicaltrials.gov) - Mar 14, 2017
P=N/A, N=40, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed | N=40 --> 60 Trial primary completion date: Feb 2017 --> Jun 2017
- Trial primary completion date: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome (clinicaltrials.gov) - Apr 28, 2016
P=N/A, N=40, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Trial primary completion date: Feb 2017 --> Jun 2017 Trial primary completion date: Dec 2015 --> Dec 2016
- Trial primary completion date: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=40, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Mar 2015 --> Dec 2015
- Trial initiation date, Trial primary completion date: Use of Copeptin in Diabetes Insipidus (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=140, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Trial primary completion date: Mar 2015 --> Dec 2015 Initiation date: Jul 2013 --> Jan 2015 | Trial primary completion date: Jul 2015 --> Dec 2018
- Trial completion, Trial primary completion date: Evaluation of a Novel Electronic Urine Output Monitor (eUOM) (clinicaltrials.gov) - Feb 27, 2015
P=N/A, N=20, Completed, Sponsor: Potrero Medical
Initiation date: Jul 2013 --> Jan 2015 | Trial primary completion date: Jul 2015 --> Dec 2018 Recruiting --> Completed | Trial primary completion date: Oct 2014 --> Feb 2015
- desmopressin / Generic mfg.
Trial completion: Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study (clinicaltrials.gov) - Dec 5, 2014
P4, N=50, Completed, Sponsor: University Hospital, Ghent
Recruiting --> Completed | Trial primary completion date: Oct 2014 --> Feb 2015 Recruiting --> Completed
- ||| desmopressin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia (clinicaltrials.gov) - Nov 20, 2014
P=N/A, N=124, Completed, Sponsor: Seoul National University Hospital
Recruiting --> Completed Recruiting --> Completed | N=200 --> 124 | Trial primary completion date: Feb 2014 --> Oct 2014
- Enrollment change, Trial withdrawal, Trial primary completion date: Severe Pelvic Organ Prolapse and Post-Obstructive Diuresis (SOPPO) Pilot Study (clinicaltrials.gov) - Aug 29, 2014
P=N/A, N=0, Withdrawn, Sponsor: Loyola University
Recruiting --> Completed | N=200 --> 124 | Trial primary completion date: Feb 2014 --> Oct 2014 N=25 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Jan 2014
- Trial primary completion date: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome (clinicaltrials.gov) - May 18, 2014
P=N/A, N=40, Recruiting, Sponsor: University Hospital, Basel, Switzerland
N=25 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Jan 2014 Trial primary completion date: Mar 2014 --> Mar 2015
- ||| desmopressin / Generic mfg.
Enrollment open: The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia (clinicaltrials.gov) - Dec 5, 2013
P=N/A, N=200, Recruiting, Sponsor: Seoul National University Hospital
Trial primary completion date: Mar 2014 --> Mar 2015 Not yet recruiting --> Recruiting
- Enrollment open: Use of Copeptin in Diabetes Insipidus (clinicaltrials.gov) - Sep 11, 2013
P=N/A, N=140, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- sildenafil / Generic mfg., indomethacin / Generic mfg., amiloride/hydrochlorothiazide / Generic mfg.
Enrollment change: Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus (clinicaltrials.gov) - Dec 18, 2012
P=N/A, N=4, Completed, Sponsor: University of Colorado, Denver
Not yet recruiting --> Recruiting N=40 --> 4
- sildenafil / Generic mfg., indomethacin / Generic mfg., amiloride/hydrochlorothiazide / Generic mfg.
Trial completion: Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus (clinicaltrials.gov) - Dec 18, 2012
P=N/A, N=4, Completed, Sponsor: University of Colorado, Denver
N=40 --> 4 Recruiting --> Completed
- desmopressin / Generic mfg.
Enrollment open: Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study (clinicaltrials.gov) - Jul 9, 2012
P4, N=50, Recruiting, Sponsor: University Hospital, Ghent
Recruiting --> Completed Not yet recruiting --> Recruiting
- desmopressin / Generic mfg.
New P4 trial: Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study (clinicaltrials.gov) - Sep 13, 2011
P4, N=50, Recruiting, Sponsor: University Hospital, Ghent